Stocks to Watch: Amazon, Masimo, Deckers
By Ben Glickman
Amazon.com's profit almost tripled in the third quarter off strong revenue growth. The e-commerce company's North America sales increased 11% and topped expectations, a sign that spending is resilient headed into the holiday season. Shares rise 4.9%, to $125.47, after-hours.
Masimo won a victory in its legal battle against Apple on Thursday, when the U.S. International Trade Commission ruled Apple had violated the medical technology's patent related to blood-oxygen reading. The commission banned the import of certain Apple Watches, though the decision could be overturned or appealed. Masimo shares rise 12%, to $90.26, after-hours.
Deckers Outdoor lifted its full-year guidance after second-quarter sales rose 25% and topped analysts' estimates. The company said it had continued to see strong demand for its Hoka sneakers and Ugg boots, helping increase profit per share by almost 80%. Shares rise 11%, to $536.11, after-hours.
Write to Ben Glickman at ben.glickman@wsj.com
(END) Dow Jones Newswires
October 26, 2023 20:08 ET (00:08 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks